Open Access Open Access  Restricted Access Subscription or Fee Access

Biotechnology Can Address the Mystery and Urgency of Alzheimer’s Disease

Mina Marmor, Henry I Miller

Abstract

Alzheimer’s disease (AD), a scourge that in time could virtually bankrupt healthcare systems worldwide, is one of the most intensively researched areas of medicine. Because of the existing uncertainty about its pathophysiology the unavailablity of reliable diagnostic tests, it is difficult to predict which prophylactic or therapeutic interventions are likely to be effective, but many biotechnology-derived drugs are prime candidates.  We summarize the most promising approaches and drugs.

Keywords

alzheimer's disease; finance

Full Text:

PDF

Refbacks

  • There are currently no refbacks.